Decreased basal production of nitric oxide in patients with heart disease

Chest

Volumn 113, Issue 2, 1998, Pages 317-322

  Sumino, Hiroyuki ^a   Sato, Kunio ^a   Sakamaki, Tetsuo ^a   Masuda, Hiroaki ^a   Nakamura, Tetsuya ^a   Kanda, Tsugiyasu ^a   Nagai, Ryozo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Cardiac index; Chemiluminescence analyzer; Hypoxic pulmonary vasoconstriction; Vascular resistance

Indexed keywords

NITRIC OXIDE;

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART DILATATION; HEART DISEASE; HEART FAILURE; HEART INDEX; HEMODYNAMIC PARAMETERS; HUMAN; HYPOXIC LUNG VASOCONSTRICTION; ISCHEMIC HEART DISEASE; LUNG VASCULAR RESISTANCE; MALE; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; PULMONARY ARTERY; VASCULAR RESISTANCE;

EID: 0031934968     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.2.317     Document Type: Article

References (40)

1. Packer M. Pathophysiology of chronic heart failure. Lancet 1992; 340:88-92
2. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-42
3. Kubo SH, Rector TS, Bank AJ, et al. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991; 84:1589-96
4. Drexler H, Hayoz D, Munzel T, et al. Endothelial function in chronic congestive heart failure. Am J Cardiol 1992; 69:1596-1601
5. Katz SD, Biasucci L, Sabba C, et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992; 19:918-25
6. Katz SD, Schwarz M, Yuen J, et al. Impaired acetyleholine-mediated vasodilation in patients with congestive heart failure: role of endothelium-derived vasodilating and vasoconstricting factors. Circulation 1993; 88:55-61
7. Drexler H, Hayoz D, Münzel T, et al. Endothelial dysfunction in chronic heart failure: experimental and clinical studies. Arzneimittelforschung 1994; 44:455-58
8. Stamler JS, Loh E, Roddy MA, et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994; 89:2035-40
9. Cooper CJ, Landzberg MJ, Anderson TJ, et al. Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans. Circulation 1996; 93:266-71
10. Habib F, Dutka D, Crossman D, et al. Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet 1994; 344:371-73
11. Gustafsson LE, Leone AM, Persson MG, et al. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991; 181: 852-57
12. Gaston B, Drazen JM, Loscalzo J, et al. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149:538-51
13. Cremona G, Higenbottam T, Takao M, et al. Exhaled nitric oxide in isolated pig lungs. J Appl Physiol 1995; 78:59-63
14. Spriestersbach R, Grimminger F, Weissmann N, et al. Online measurement of nitric oxide generation in buffer-perfused rabbit lungs. J Appl Physiol 1995; 78: 1502-08
15. Sato K, Sakamaki T, Sumino H, et al. Rate of nitric oxide release in the lung and factors influencing the concentration of exhaled nitric oxide. Am J Physiol 1996; 270:L914-20
16. Ontkean M, Gay R, Greenberg B. Diminished endothelium-derived relaxing factor activity in an experimental model of chromic heart failure. Circ Res 1991; 69:1088-96
17. G-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res 1993; 72:387-95
18. Nakaike R, Shimokawa H, Yasutake H, et al. Effects of L-arginine analogues on vasomotion of isolaled porcine coronary arteries. Am J Physiol 1995; 268:H1966-72
19. Winlaw DS, Smythe GA, Keogli AM, et al. Increased nitric oxide production in heart failure. Lancet 1994; 344:373-74
20. Zeballos GA, Bernstein RD, Thompson CI, et al. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation 1995; 91: 2982-88
21. Grimminger F, Spriestersbach R, Weissmann N, et al. Nitric oxide generation and hypoxie vasoconstriction in buffer-perfused rabbit lungs. J Appl Physiol 1995; 78:1509-15
22. Zellers TM, McCormick J, Wu Y. Interaction among ET-1, endothelium-derived nitric oxide, and prostacyclin in pulmonary arteries and veins. Am J Physiol 1994; 267:H139-47
23. Shaul PW, Kinane B, Farrar MA, et al. Prostacyclin production and mediation of adenylate cyclase activity in the pulmonary artery: alterations after prolonged hypoxia in the rat. J Clin Invest 1991; 88:447-55
24. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993; 328:1732-39
25. Smith CJ, Sun D, Hoegler C, et al. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res 1996; 78:58-64
26. Wang J, Seyedi N, Xu XB, et al. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol 1994; 266:H670-80
27. Voelkel NF. Mechanisms of hypoxic pulmonary vasoconstriction. Am Rev Respir Dis 1986; 133:1186-95
28. Shaul PW, Wells LB, Horning KM. Acute and prolonged hypoxia attenuate endothelial nitric oxide production in rat pulmonary arteries by different mechanisms. J Cardiovasc Pharmacol 1993; 22:819-27
29. Barer G, Emery C, Stewart A, et al. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats. J Physiol Lond 1993; 463:1-16
30. Shaul PW, North AJ, Brannon TS, et al. Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung. Am J Respir Cell Mol Biol 1995; 13:167-74
31. Leeman M, de Beyl VZ, Delcroix M, et al. Effects of endogenous nitric oxide on pulmonary vascular tone in intaet dogs. Am J Physiol 1994; 266:H2343-47
32. Dinh XA, Pepke ZJ, Butt AY, et al. Impairment of pulmonary-artery endothelium-dependent relaxation in chronic obstructive lung disease is not due to dysfunction of endothelial cell membrane receptors nor to L-arginine deficiency. Br J Pharmacol 1993; 109:587-91
33. McQuillan LP, Leung GK, Marsden PA, et al. Hypoxia inhihits expression of eNOS via transcriptional and post-transcriptional mechanisms. Am J Physiol 1994; 267: H1921-27
34. Miller VM, Burnett JCJ. Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries. Am J Physiol 1992; 263:H103-08
35. Hughes JM, Glazier JB, Rosenzweig DY, et al. Factors determining the distribution of pulmonary blood flow in patients with raised pulmonary venous pressure. Clin Sci 1969; 37:847-58
36. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992; 90:2548-54
37. Panza JA, Quyyumi AA, Brush JJ, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323:22-27
38. Casino PR, Kileoyne CM, Quyyumi AA, et al. The role of nitric oxide in endothelium-dependent vasodilation of hyper cholesterolemic patients. Circulation 1993; 88:2541-47
39. Woolfson RG, Poston L. Effect of onabain on endothelium-dependent relaxation of human resistance arteries. Hypertension 1991; 17:619-25
40. Warren JB, Loi RK. Captopril increases skin microvascular blood flow secondary to bradykinin, nitric oxide, and prostaglandins. FASEB J 1995; 9:411-18